top of page
external-file_edited.png

Videos | Webinar: New Treatment for PV with Prof. Susanne Isfort and Silence Therapeutics

Last August 28th, the Global MPN Scientific Foundation hosted a special webinar together with Silence Therapeutics, a biotech company developing precision RNA-based therapies for rare diseases such as Polycythemia Vera (PV).


This session brought together:

  • Prof. Susanne Isfort, hematologist, clinical researcher, and MPN expert from Germany.

  • Alberto Martinez, Senior Director of Clinical Science at Silence Therapeutics.


Together, they explored new ways to approach PV through clinical trials and innovative treatments.


Last August 28th, the Global MPN Scientific Foundation hosted a special webinar together with Silence Therapeutics, a biotech company developing precision RNA-based therapies for rare diseases such as Polycythemia Vera (PV).

Content guide



Part 1: Silence Therapeutics and a Promising New Treatment for PV

In the first part, Alberto Martinez explained the science behind divesiran, a therapy currently in development for PV, and how Silence Therapeutics is advancing innovative approaches that could help reduce phlebotomies and improve quality of life. Full video:




Watch More on MPN World

In addition to Part 1, the webinar also includes:

  • Part 2: The influence of iron in PV patients with Prof. Susanne Isfort

  • Part 3: Experience of patients with PV in a clinical trial



If you are not yet a member of MPN World or are not a patient, contact us at info@gmpnsf.org and we’ll respond as quickly as possible.

Comments


bottom of page